We are looking for children and teens 2–17 years of age to join a Crohn’s disease (CD) medical research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or CD (including associated symptoms such as rectal pain, fatigue, constant need to poop, chronic fatigue and/or liver disease), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

We are looking for children and teens 2–17 years of age to join a CD research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or gastrointestinal disease (including associated symptoms such as chronic diarrhea, blood in the stool, abdominal pain, weight loss and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

We are looking for young people 2–17 years old to join a CD trial to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or moderately to severely active ulcerative colitis (including associated symptoms such as tiredness, inflammation of the bowel or intestine, diarrhea, frequent fevers and/or eye pain), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing UC flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce tiredness, stomach pain, constant need to poop, malnutrition, and/or liver disease associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce long-term diarrhea, stomach pain, diarrhea, frequent fevers, and/or eye pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

Is your child currently experiencing CD and UC flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce abdominal pain, reduced appetite, diarrhea, chronic fatigue, and/or liver disease associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for young people 2 to 17 years old to join a research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or ulcerative colitis (including associated symptoms such as long-term diarrhea, fatigue, rectal pain, malnutrition and/or canker sores), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing CD and UC flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce urgency to defecate, failure to thrive, rectal pain, malnutrition, and/or eye pain associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2 to 17 years of age to join a clinical trial to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or CD (including associated symptoms such as painful joints, fever, cramps, weight loss and/or anemia), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease (CD) study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or CD and UC (including associated symptoms such as cramps, weight loss, abdominal pain, frequent fevers and/or anemia), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.